VGI Health Technology Limited (NSX:VTL) Term Sheet for Sale

VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.

Related Keywords

Australia , Monash , South Australia , Japan , United States , Canada , Sydney , New South Wales , Australian , America , Christopher Porter , Steven Yu , Richard Estalella , Dinvictus Group , Monash University , Monash Institute Of Pharmaceutical Sciences , Health Technology Limited , Invictus Biotechnology Pty Ltd , Invictus Nutraceuticals Inc , Health Technology , Corporate Affairs , Term Sheet , Invictus Biopharma , Technology Limited , Invictus Biopharma Pty Ltd Group , Invictus Biopharma Holdings Ltd , Managing Director , Scientific Officer , Scientific Advisory Board , Exclusivity Period , Share Purchase Agreement , Key Terms , Invictus Biotechnology Pty , Invictus Nutraceuticals , Peoples Republic , Corporations Act , Independent Expert , Listed Medicines , Management Changes , Drs Tong , South America , Executive Chairman , Chief Medical Officer , Executive Director , Vice President , Non Alcoholic Fatty Liver Disease , Non Alcoholic Steatohepatitis , Pancreatic Adenocarcinoma , Pancreatic Cancer , Professor Christopher Porter , Monash Institute , Pharmaceutical Sciences , Delayed Onset Muscle Soreness , Biotech , Clinical Trials , Drugs Otc , Vgi Health Technology Limited , Nsx Vtl ,